People: CSPC Pharmaceutical Group Ltd (1093.HK)
25 Jun 2019
Mr. Cai Dongchen is Executive Chairman of the Board, Chief Executive Officer of the Company. Mr. Cai is also the chairman of the Nomination Committee of the Company and a director of certain subsidiaries of the Group. Mr. Cai holds a MBA degree from Nankai University and has extensive technical and management experience in the pharmaceutical industry. Mr. Cai is a substantial shareholder of the Company within the meaning of Part XV of the Securities and Futures Ordinance (“SFO”). Mr. Cai is also a director of True Ally Holdings Limited and Massive Giant Group Limited, both are substantial shareholders of the Company within the meaning of Part XV of the SFO.
|Total Annual Compensation, HKD||12,925,000|
|Restricted Stock Award, HKD||--|
|Long-Term Incentive Plans, HKD||--|
|All Other, HKD||403,000|
|Fiscal Year Total, HKD||13,328,000|